Influenza

© GettyImages/Design Cells

AstraZeneca invests in saRNA specialist

By Jane Byrne

AstraZeneca has announced a long-term research collaboration with VaxEquity for the discovery, development and commercialization of its self-amplifying RNA (saRNA) therapeutics platform.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers